CN100391531C - Externally applied Chinese medicine preparation for treating hyperosteogeny - Google Patents
Externally applied Chinese medicine preparation for treating hyperosteogeny Download PDFInfo
- Publication number
- CN100391531C CN100391531C CNB200410091054XA CN200410091054A CN100391531C CN 100391531 C CN100391531 C CN 100391531C CN B200410091054X A CNB200410091054X A CN B200410091054XA CN 200410091054 A CN200410091054 A CN 200410091054A CN 100391531 C CN100391531 C CN 100391531C
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- chinese medicine
- hyperosteogeny
- moschus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 22
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 18
- 235000008397 ginger Nutrition 0.000 claims abstract description 18
- 244000153234 Hibiscus abelmoschus Species 0.000 claims abstract description 15
- 239000009286 sanguis draxonis Substances 0.000 claims abstract description 15
- 235000006463 Brassica alba Nutrition 0.000 claims abstract description 3
- 244000140786 Brassica hirta Species 0.000 claims abstract description 3
- 241001506304 Kadsura japonica Species 0.000 claims abstract description 3
- 241000234314 Zingiber Species 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 14
- 241000196324 Embryophyta Species 0.000 claims description 6
- 241000717739 Boswellia sacra Species 0.000 claims description 4
- 241000903946 Clematidis Species 0.000 claims description 4
- 241000283956 Manis Species 0.000 claims description 4
- 241001057584 Myrrha Species 0.000 claims description 4
- 235000011837 pasties Nutrition 0.000 claims 1
- 210000000115 thoracic cavity Anatomy 0.000 abstract description 5
- 239000004863 Frankincense Substances 0.000 abstract description 3
- 241000402754 Erythranthe moschata Species 0.000 abstract 4
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 4
- 244000273928 Zingiber officinale Species 0.000 abstract 4
- 239000009136 dragon's blood Substances 0.000 abstract 4
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 235000011371 Brassica hirta Nutrition 0.000 abstract 1
- 235000002566 Capsicum Nutrition 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 239000006002 Pepper Substances 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 235000016761 Piper aduncum Nutrition 0.000 abstract 1
- 235000017804 Piper guineense Nutrition 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 235000008184 Piper nigrum Nutrition 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 210000000474 heel Anatomy 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- RZZPDXZPRHQOCG-OJAKKHQRSA-M CDP-choline(1-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-M 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000000459 calcaneus Anatomy 0.000 description 1
- 229960001284 citicoline Drugs 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000009064 mailuoning Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000003058 plasma substitute Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an external application traditional Chinese medicine preparation for treating hyperosteogeny, which is a series of formulas, comprises A, B, C, D four formulas and is respectively used for treating hyperosteogeny lesions of cervical vertebra, thoracic vertebra, lumbar vertebra and heel part, wherein each formula must contain at least the following components: caulis Spatholobi, Moschus, sanguis Draxonis, rhizoma Zingiberis recens, and Chinese liquor. Prescription A contains 10 parts of caulis Spatholobi; 0.05 part of musk; 5 parts of dragon's blood; 50 parts of fresh ginger; 10 parts of frankincense; 10 parts of kadsura pepper stem; and appropriate amount of white spirit. Prescription B contains 10 parts of caulis Spatholobi; 0.05 part of musk; 5 parts of dragon's blood; 50 parts of fresh ginger; 10 parts of white mustard seed; 10 parts of rhizoma drynariae; 10 parts of rhizoma cibotii; and appropriate amount of white spirit. Prescription C contains 10 parts of caulis Spatholobi; 10 parts of musk; 10 parts of dragon's blood; 10 parts of fresh ginger; 10 parts of clematis root; 10 parts of pangolin; and appropriate amount of white spirit. Prescription D contains 10 parts of caulis Spatholobi; 10 parts of musk; 10 parts of dragon's blood; 50 parts of fresh ginger; 10 parts of rhizoma drynariae; 10 parts of radix angelicae pubescentis; 10 parts of myrrh; and appropriate amount of white spirit.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of hyperosteogeny, particularly a kind of preparation that is used for the treatment of the Traditional Chinese Medicine for external application prescription of hyperosteogeny.
Background technology
In the prior art medicine of treatment hyperosteogeny nothing more than be ball, pellet, loose, oral formulations or liniment such as sheet, but poor effect during these Drug therapys.Reason is that primary disease is the locality pathological changes, as finding according to clinical experience, it is positions such as cervical vertebra, lumbar vertebra, thoracic vertebra, knee joint and calcaneus that hyperosteogeny is easily sent out the position, because above-mentioned position is former thereby tired because of work, and then generation soft tissue local inflammation, cause blood circulation generation obstacle, degeneration will take place in soft tissue, so-called hyperosteogeny that Here it is.For this locality pathological changes, the effect of oral medication naturally can not can ratio with the effect of external application for curing, adopt when carrying out the treatment of primary disease clinically external application for curing generally can be in 1-2 days relief of symptoms.
Summary of the invention
The object of the present invention is to provide a kind of Traditional Chinese Medicine for external application preparation that is used for the treatment of hyperosteogeny.Its therapeutic effect when external application is obvious.
The Traditional Chinese Medicine for external application preparation that is used for the treatment of hyperosteogeny of the present invention is serial prescription, comprise A, B, four prescriptions of C, D, be respectively applied for the osteoproliferation pathological changes of treatment cervical vertebra, thoracic vertebra, lumbar vertebra and heel portion, wherein must contain in each prescription and descend component at least: Caulis Spatholobi, Moschus, Sanguis Draxonis, fresh ginger, Chinese liquor.
Wherein contain 10 parts of Caulis Spatholobis in the A prescription; 0.05 part in Moschus; 5 parts of Sanguis Draxonis; 52 parts of fresh gingers; 10 parts of Olibanums; 10 parts of Caulis Piperis Kadsuraes; Chinese liquor is an amount of.
Wherein contain 10 parts of Caulis Spatholobis in the B prescription; 0.05 part in Moschus; 5 parts of Sanguis Draxonis; 52 parts of fresh gingers; 10 parts of Semen Sinapis Albaes; 10 parts of Rhizoma Drynariae; 10 parts of Rhizoma Cibotii; Chinese liquor is an amount of.
Wherein contain 10 parts of Caulis Spatholobis in the C prescription; 10 parts in Moschus; 10 parts of Sanguis Draxonis; 10 parts of fresh gingers; 10 parts of Radix Clematidis; 10 parts of Squama Maniss; Chinese liquor is an amount of.
Wherein contain 10 parts of Caulis Spatholobis in the D prescription; 10 parts in Moschus; 10 parts of Sanguis Draxonis; 50 parts of fresh gingers; 10 parts of Rhizoma Drynariae; 10 parts of Radix Angelicae Pubescentiss; 10 parts of Myrrhas; Chinese liquor is an amount of.
With the PPC-45A type cracker for medicine that machinery plant of University Of Qingdao produces the name component is pulverized, and crossed the 200-300 mesh sieve, extracting screen underflow is a product of the present invention.
According to above prescription finishing analysis, be can invigorate blood circulation activating blood circulation to dissipate blood stasis, channels sootheing and network vessel quickening of monarch drug with Olibanum, Myrrha, Caulis Spatholobi, Caulis Piperis Kadsurae, Rhizoma Drynariae.With Squama Manis, Moschus, Sanguis Draxonis is the pain relieving of ministerial drug promoting blood circulation to remove blood stasis, has one's ideas straightened out that it is dirty to ward off, and is good at walking the effect of break-through key.With Rhizoma Cibotii, Radix Clematidis compatibility current 12 warps are arranged, the strong strong ridge of muscle.With the ginger wine is messenger drug, through dispelling cold by warming the meridian, exploitation pore, makes drug effect see through subcutaneous tissue and reaches the effect of preventing or cure a disease.
A prescription wherein is mainly used in the hyperosteogeny at treatment cervical vertebra position, and B prescription wherein is mainly used in the hyperosteogeny at treatment thoracic vertebra position; C prescription wherein is mainly used in the hyperosteogeny at treatment lumbar vertebra position; Wherein the D prescription is mainly used in the hyperosteogeny at treatment heel position.
This prescription compares with other medicine, and advantage is that medicine is non-volatile, efficacy stability, and external application can be played direct effect.Evident in efficacy, can alleviate with second day symptom after 1 dose, and can reach the purpose of radical cure, bony spur can not recur after disappearing.
The specific embodiment
The preparation of preparation A side.Take by weighing Caulis Spatholobi 100 grams respectively; Moschus 0.5 gram; Sanguis Draxonis 50 grams; Fresh ginger 500 grams; Olibanum 100 grams; Caulis Piperis Kadsurae 100 grams; Above-mentioned each material is medicinal part siccative amount commonly used, and above-mentioned each component materials is mixed, and the PPC-45A type cracker for medicine of producing with machinery plant of University Of Qingdao is ground into fine powder, goes siftage just to form A side of the present invention siccative agent.Mix into pastel with proper amount of white spirit and its mixing during use and just can apply the affected part.
The preparation of preparation B side.Take by weighing Caulis Spatholobi 100 grams respectively; Moschus 0.5 gram; Sanguis Draxonis 50 grams; Fresh ginger 500 grams; Semen Sinapis Albae 100 grams; Rhizoma Drynariae 100 grams; Rhizoma Cibotii 100 grams; Above-mentioned each material is medicinal part siccative amount commonly used, and above-mentioned each component materials is mixed, and the PPC-45A type cracker for medicine of producing with machinery plant of University Of Qingdao is ground into fine powder, goes siftage just to form B side of the present invention siccative agent.Mix into pastel with proper amount of white spirit and its mixing during use and just can apply the affected part.
The preparation of preparation C side.Take by weighing Caulis Spatholobi 100 grams respectively; Moschus 100 grams; Sanguis Draxonis 100 grams; Fresh ginger 100 grams; Radix Clematidis 100 grams; Squama Manis 100 grams; Above-mentioned each material is medicinal part siccative amount commonly used, and above-mentioned each component materials is mixed, and the PPC-45A type cracker for medicine of producing with machinery plant of University Of Qingdao is ground into fine powder, goes siftage just to form C side of the present invention siccative agent.Mix into mushy stool with proper amount of white spirit and its mixing during use and can apply the affected part.
The preparation of preparation D side.Take by weighing Caulis Spatholobi 100 grams respectively; Moschus 0.5 gram; Sanguis Draxonis 100 grams; Fresh ginger 500 grams; Rhizoma Drynariae 100 grams; Radix Angelicae Pubescentis 100 grams; Myrrha 100 grams; Above-mentioned each material is medicine position commonly used siccative amount, and above-mentioned each component materials is mixed, and the PPC-45A type cracker for medicine of producing with machinery plant of University Of Qingdao is ground into fine powder, goes siftage just to form D side of the present invention siccative agent.Mix into pastel with proper amount of white spirit and its mixing during use and just can apply the affected part.
Above-mentioned A side is used for the treatment of the hyperosteogeny at cervical vertebra position, clinical manifestation for headache, dizzy, feel sick, vomiting, dim eyesight, diplopia, numb hand and foot, neck shoulder back are ached, severe patient ataxia, instability of gait, lose work capacity.
Above-mentioned B side is used for the treatment of the hyperosteogeny at thoracic vertebra position, and clinical manifestation is ached, radiated in neck and shoulder part, disease of hand for headache, dizziness, shoulder back.
Above-mentioned C side is used for the treatment of the hyperosteogeny at lumbar vertebra position, shows as waist acupuncture sample pain, aggravation when movable; Pain is radiated to shank.
Above-mentioned D side is used for the treatment of the bony spur at heel position, shows as heel distending pain, the sense of acupuncture sample, increases the weight of when standing walking.
The success clinical case:
Sun Liying, the man, 62 years old, hot spring people from town in Jimo City's went to a doctor on October 28th, 1998, with 706 plasma substitutes, MAILUONING, citicoline passages through which vital energy circulates instil treat all invalid.Then take preparation of the present invention to carry out the hyperosteogeny external application for curing, use A side of the present invention after, 1 dose with after, sx, recovery from illness after 3 doses of the medications, recovery from illness has so far 6 years more and does not see recurrence certainly.
Yu Qiaofang, the woman, 74 years old, the retired worker of Jimo City, on January 8th, 2000 went to a doctor, and this suffered from hyperosteogeny of cervical vertebra 34 years, did not all have obvious curative effects in how tame hospitalize, with transference cure behind this product A side, not recurrence more than 4 years after the recovery from illness.
Jiang Dunwei, the man, 54 years old, people from development zone, Jimo City went to a doctor on February 16th, 2003, suffered from thoracic dorsal vertebrae hyperosteogeny 24 years, took transference cure recovery from illness behind 6 doses of this product B sides.
Lan Xinfeng, the man, 72 years old, dragon's fountain people from town in Jimo City's went to a doctor January 12 calendar year 2001, is lumbar vertebra hyperosteogeny, took recovery from illness behind 3 doses of this product C sides, do not see recurrence 3 years later on more.
Director Wang, man, 42 years old, the director of place, gardens, Jimo City.Suffered from hyperosteogeny of cervical vertebra 5 years, multi-treatment is invalid.On February 18th, 2002 went to a doctor, and took the 4 back recoveries from illness of this product A side, did not see recurrence so far.
Wei Zhen, woman, 70 years old, Hulin, Heilongjiang Province people from county, went to a doctor on June 18th, 2000, symptom is a spur in heels, i.e. heel position hyperosteogeny, take 2 doses of this product D sides after symptom obviously alleviate, after again in calendar year 2001 recurrence, take the 2 doses of recoveries from illness in this product D side once more, so far recurrence.
Liu Guifang, the woman, 60 years old, people from development zone, Jimo City, the retired worker suffered from knee joint hyperosteogeny 5 years, and is invalid through multi-treatment.Go to a doctor in June, 2003, takes recovery from illness behind 6 doses of this product D sides, recurrence.
This year, this product was treated various hyperosteogeny 141 examples altogether, wherein cured rehabilitation 134 examples, cure rate 95%.
Claims (5)
1. Traditional Chinese Medicine for external application preparation that is used for the treatment of hyperosteogeny is characterized in that: make said preparation crude drug consist of 10 parts of Caulis Spatholobis; 0.05 part in Moschus; 5 parts of Sanguis Draxonis; 50 parts of fresh gingers; 10 parts of Olibanums; 10 parts of Caulis Piperis Kadsuraes; Chinese liquor is an amount of.
2. Chinese medicine preparation according to claim 1 is characterized in that: make said preparation crude drug consist of 10 parts of Caulis Spatholobis; 0.05 part in Moschus; 5 parts of Sanguis Draxonis; 50 parts of fresh gingers; 10 parts of Semen Sinapis Albaes; 10 parts of Rhizoma Drynariae; 10 parts of Rhizoma Cibotii; Chinese liquor is an amount of.
3. Chinese medicine preparation according to claim 1 is characterized in that: make said preparation crude drug consist of 10 parts of Caulis Spatholobis; 10 parts in Moschus; 10 parts of Sanguis Draxonis; 10 parts of fresh gingers; 10 parts of Radix Clematidis; 10 parts of Squama Maniss; Chinese liquor is an amount of.
4. Chinese medicine preparation according to claim 1 is characterized in that: make said preparation crude drug consist of 10 parts of Caulis Spatholobis; 10 parts in Moschus; 10 parts of Sanguis Draxonis; 50 parts of fresh gingers; 10 parts of Rhizoma Drynariae; 10 parts of Radix Angelicae Pubescentiss; 10 parts of Myrrhas; Chinese liquor is an amount of.
5. one kind as any one described preparation method that is used for the treatment of the Traditional Chinese Medicine for external application preparation of hyperosteogeny in the claim 1 to 4, it is characterized in that: each component is pulverized with the PPC-45A type cracker for medicine that machinery plant of University Of Qingdao produces, and mistake 200-300 mesh sieve, it is pasty state that extracting screen underflow is in harmonious proportion with white spirit mixed, promptly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410091054XA CN100391531C (en) | 2004-11-17 | 2004-11-17 | Externally applied Chinese medicine preparation for treating hyperosteogeny |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410091054XA CN100391531C (en) | 2004-11-17 | 2004-11-17 | Externally applied Chinese medicine preparation for treating hyperosteogeny |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1775281A CN1775281A (en) | 2006-05-24 |
CN100391531C true CN100391531C (en) | 2008-06-04 |
Family
ID=36765080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200410091054XA Expired - Fee Related CN100391531C (en) | 2004-11-17 | 2004-11-17 | Externally applied Chinese medicine preparation for treating hyperosteogeny |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100391531C (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102698239A (en) * | 2012-06-28 | 2012-10-03 | 王欣宜 | Traditional Chinese medicine preparation for treating shoulder periarthritis |
CN103494909B (en) * | 2013-09-25 | 2016-01-20 | 赵新刚 | A kind of Chinese medicine composition for the treatment of comminuted bone injury |
CN105012909A (en) * | 2015-07-27 | 2015-11-04 | 英成楼 | Externally-applied agent for treating pains in bones and muscles and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1248454A (en) * | 1998-09-18 | 2000-03-29 | 刘维增 | Jingtongtie plaster for treating cervicodynia and preparation process |
CN1365827A (en) * | 2002-02-04 | 2002-08-28 | 陈玉周 | Exterior-applied medicine for treating osteopathy |
-
2004
- 2004-11-17 CN CNB200410091054XA patent/CN100391531C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1248454A (en) * | 1998-09-18 | 2000-03-29 | 刘维增 | Jingtongtie plaster for treating cervicodynia and preparation process |
CN1365827A (en) * | 2002-02-04 | 2002-08-28 | 陈玉周 | Exterior-applied medicine for treating osteopathy |
Non-Patent Citations (1)
Title |
---|
中医药治疗骨质增生概述. 孙锋等.河南中医药学刊,第9卷第6期. 1994 * |
Also Published As
Publication number | Publication date |
---|---|
CN1775281A (en) | 2006-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101843873B (en) | Muscle-nourishing bone-strengthening ointment | |
CN106492133A (en) | A kind of reunion of bone, blood circulation promoting and blood stasis dispelling, the Chinese medicine plaster of reducing swelling and alleviating pain and preparation method | |
CN103585590B (en) | Rheumatism ostalgia plaster | |
CN104474293A (en) | Traditional Chinese medicine ointment for treating hyperosteogeny and preparing method thereof | |
CN105381146A (en) | Traditional Chinese medicine package for treating rheumatic pain and using method thereof | |
CN101549137A (en) | Chinese medicine preparation for treating bone joint disease | |
CN101396541B (en) | Traditional Chinese medicine for treating the cervical vertebra disease | |
CN102266542B (en) | Ointment patch for treating hyperosteogeny and preparation method thereof | |
CN100391531C (en) | Externally applied Chinese medicine preparation for treating hyperosteogeny | |
CN101244135B (en) | Medicine label for treating rheumatism, hyperosteogeny | |
CN106177819A (en) | A kind of external medicine composition for cervical spondylosis, preparation method and applications | |
CN105902969A (en) | External-use drug for treating pain in waist and lower extremities, process and application | |
CN105456977A (en) | Plaster for treating pains on neck, shoulder, waist and leg | |
CN1201765C (en) | Chinese medicine ointment for treating arthrosis | |
CN101433647B (en) | Plaster for treating femoral head necrosis and preparation method thereof | |
CN101612213B (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion | |
CN105687944A (en) | Traditional Chinese medicine composition for treating cervical spondylosis and lumbar spondylosis | |
CN101168041B (en) | Rheumatism treating medicine | |
CN104666673A (en) | Traditional Chinese medicine composition and self-heating protective equipment | |
CN105816619A (en) | Traditional Chinese medicine prescription capable of removing toxic substances and eliminating arthritis | |
CN104771432A (en) | Traditional Chinese medicine for treating fracture | |
CN1935237A (en) | Emplastrum for injury, bone, flatulence relieving and inflammation and its use | |
CN103721183B (en) | A kind of Chinese medicine composition for the treatment of middle-aged and elderly people lumbago and skelalgia | |
CN100404065C (en) | Externally-applied medicinal liquid for treating rheumatalgia and wound and its preparation | |
CN101332288B (en) | Traditional Chinese medicine knee-cap and making method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080604 Termination date: 20101117 |